期刊(kan)中文名:泌尿(niao)科學ISSN:1879-5226E-ISSN:1879-5234
該雜志(zhi)國際簡稱(cheng):UROL SCI,是由出(chu)版商Wolters Kluwer Medknow Publications出(chu)版的(de)一本致力于(yu)發布(bu)--研究新(xin)成(cheng)果的(de)的(de)專業學(xue)(xue)術(shu)期刊。主要發表(biao)刊登(deng)有創見的(de)學(xue)(xue)術(shu)論(lun)文文章(zhang)、行業最(zui)新(xin)科研成(cheng)果,扼要報道(dao)階段性(xing)研究成(cheng)果和重要研究工作(zuo)的(de)最(zui)新(xin)進展(zhan),選載對學(xue)(xue)科發展(zhan)起指導作(zuo)用的(de)綜述與專論(lun),促進學(xue)(xue)術(shu)發展(zhan),為(wei)廣大讀(du)者(zhe)服務。該刊是一本國際優秀雜志(zhi),在國際上(shang)有很高的(de)學(xue)(xue)術(shu)影響(xiang)力。
《Urological Science》是一本(ben)以English為主的(de)(de)(de)(de)開放獲取(qu)國(guo)際優秀期刊,中文名稱泌尿科學,本(ben)刊主要出版、報(bao)道(dao)領域的(de)(de)(de)(de)研(yan)究動態以及在該領域取(qu)得的(de)(de)(de)(de)各方面的(de)(de)(de)(de)經驗(yan)和科研(yan)成果(guo),介紹該領域有關本(ben)專業(ye)的(de)(de)(de)(de)最新進展(zhan),探討行業(ye)發(fa)展(zhan)的(de)(de)(de)(de)思路和方法(fa),以促進學術(shu)信息交流(liu),提高行業(ye)發(fa)展(zhan)。該刊已被(bei)國(guo)際權威數據庫SCIE收錄,為該領域相關學科的(de)(de)(de)(de)發(fa)展(zhan)起到(dao)(dao)了(le)良(liang)好的(de)(de)(de)(de)推動作用,也得到(dao)(dao)了(le)本(ben)專業(ye)人員的(de)(de)(de)(de)廣(guang)泛認可。該刊最新影響因子(zi)為0.8,最新CiteScore 指數為1.2。
Urological Science is an internationally peer-reviewed journal dedicated to the field of urology, covering the prevention, diagnosis, treatment, and related basic research of urological diseases. It aims to provide a high-quality research exchange platform for urologists, researchers, and healthcare professionals worldwide. The content of this magazine may include but is not limited to research on prostate diseases, urinary tract infections, urinary stones, urinary system tumors, urinary incontinence, male reproductive health, and other related areas.
Its characteristics lie in its attention to the latest research in urology and its preference for research articles with strong clinical applicability. The importance of this journal lies in its contribution to improving the research level and clinical practice of urology, as well as its recognition as an internationally recognized publishing channel.
Through a rigorous peer review process, this journal ensures that published research has high academic standards and clinical relevance.
按JIF指標學科分(fen)區 |
學科:UROLOGY & NEPHROLOGY
收錄子集:ESCI
分區:Q4
排名:102 / 126
百分位:
19.4% |
按JCI指標學科分區 |
學科:UROLOGY & NEPHROLOGY
收錄子集:ESCI
分區:Q4
排名:109 / 126
百分位:
13.89% |
JCR分區:JCR分(fen)(fen)區(qu)(qu)來(lai)自科睿唯安公司,JCR是(shi)一(yi)(yi)個(ge)獨特的多(duo)學科期(qi)(qi)(qi)刊(kan)評價(jia)工具(ju),為(wei)(wei)唯一(yi)(yi)提供基(ji)于引文數據的統計信(xin)息的期(qi)(qi)(qi)刊(kan)評價(jia)資(zi)源。每年(nian)發布的JCR分(fen)(fen)區(qu)(qu),設置了254個(ge)具(ju)體學科。JCR分(fen)(fen)區(qu)(qu)根據每個(ge)學科分(fen)(fen)類按照期(qi)(qi)(qi)刊(kan)當年(nian)的影響因(yin)子高低(di)將期(qi)(qi)(qi)刊(kan)平均分(fen)(fen)為(wei)(wei)4個(ge)區(qu)(qu),分(fen)(fen)別為(wei)(wei)Q1、Q2、Q3和(he)Q4,各占25%。JCR分(fen)(fen)區(qu)(qu)中期(qi)(qi)(qi)刊(kan)的數量是(shi)均勻分(fen)(fen)為(wei)(wei)四(si)個(ge)部分(fen)(fen)的。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Urology | Q3 | 80 / 120 |
33% |
該雜志(zhi)(zhi)是一本(ben)國(guo)(guo)際(ji)優(you)秀(xiu)雜志(zhi)(zhi),在國(guo)(guo)際(ji)上有較高的學(xue)術(shu)影響力,行業關注度很(hen)高,已(yi)被(bei)國(guo)(guo)際(ji)權威(wei)數(shu)據庫SCIE收錄,該雜志(zhi)(zhi)在綜合專(zhuan)業領(ling)域專(zhuan)業度認可(ke)很(hen)高,對(dui)稿(gao)(gao)(gao)件內(nei)容的創新性(xing)和(he)學(xue)術(shu)性(xing)要求很(hen)高,作為(wei)一本(ben)國(guo)(guo)際(ji)優(you)秀(xiu)雜志(zhi)(zhi),一般投稿(gao)(gao)(gao)過審(shen)時間都較長(chang),投稿(gao)(gao)(gao)過審(shen)時間平均 6 Weeks ,如果(guo)想投稿(gao)(gao)(gao)該刊要做好時間安排。版面費不祥。該雜志(zhi)(zhi)近兩年未(wei)被(bei)列入(ru)預警名單,建議您投稿(gao)(gao)(gao)。如您想了解(jie)更多投稿(gao)(gao)(gao)政策及投稿(gao)(gao)(gao)方案(an),請咨詢客服(fu)。
若用戶需(xu)要(yao)出(chu)版(ban)服務,請聯系(xi)出(chu)版(ban)商。